Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin
Clinical trial NCT06031454 · COMPLETED
Trial details
- NCT number
- NCT06031454
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-11-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.